STOCK TITAN

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) Financials

HROWM
Trailing 12 months to March 31, 2026
Revenue $268.7M +26.2% YoY
Net Income -$15.0M +31.0% YoY
EPS (Diluted) -$0.14 FY2025 annual
Free Cash Flow $14.3M +3295.0% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HROWM SEC filings page.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) reported $268.7M in revenue over the twelve months to Mar 31, 2026, up 26.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HROWM FY2025

Operating leverage is emerging: stable gross margins are turning rapid sales growth into operating profit, but financing costs still suppress net earnings.

Gross margin stayed near 75.0% across FY2024-FY2025, while operating margin reached 11.2% in FY2025; the profit step-up reflects better operating-cost absorption rather than a changed gross-profit engine. Interest expense of $24.2M consumed most of FY2025's $30.5M operating income, so financing costs remain the bridge between operating profitability and bottom-line losses.

Cash conversion reversed sharply: operating cash flow moved from -$22.2M in FY2024 to $43.9M in FY2025, indicating that the operating improvement reached reported cash rather than staying in accrual earnings. Free cash flow reached $43.0M alongside $110.9M of receivables, showing improved cash generation while a large amount of sales remained tied up in customer balances.

Leverage increased: debt-to-equity rose from 3.8x in FY2024 to 4.8x in FY2025 even as operating margin improved, so earnings progress has not yet reduced balance-sheet dependence.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Harrow, Inc. 11.875% Senior Notes due 2027 does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Neutral
6/9

Harrow, Inc. 11.875% Senior Notes due 2027 passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

Harrow, Inc. 11.875% Senior Notes due 2027 reported a net loss of $5.1M while generating $43.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
1.26x

Harrow, Inc. 11.875% Senior Notes due 2027 earns $1.26 in operating income for every $1 of interest expense ($30.5M vs $24.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$44.2M
YoY-7.6%
QoQ-50.4%
5Y CAGR+23.4%
10Y CAGR+26.0%

Harrow, Inc. 11.875% Senior Notes due 2027 generated $44.2M in revenue in Q1 2026. This represents a decrease of 7.6% from the same quarter a year earlier. Against the prior quarter it is down 50.4%.

EBITDA
-$21.6M
YoY-100.8%
QoQ-232.1%

Harrow, Inc. 11.875% Senior Notes due 2027's EBITDA was -$21.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 100.8% from the same quarter a year earlier. Against the prior quarter it is down 232.1%.

Net Income
-$27.6M
YoY-55.2%
QoQ-516.6%

Harrow, Inc. 11.875% Senior Notes due 2027 reported -$27.6M in net income in Q1 2026. This represents a decrease of 55.2% from the same quarter a year earlier. Against the prior quarter it is down 516.6%.

EPS (Diluted)
-$0.74
YoY-48.0%

Harrow, Inc. 11.875% Senior Notes due 2027 earned -$0.74 per diluted share (EPS) in Q1 2026. This represents a decrease of 48.0% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow
-$9.2M
YoY-147.1%
QoQ-213.8%

Harrow, Inc. 11.875% Senior Notes due 2027 recorded an outflow of $9.2M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 147.1% from the same quarter a year earlier. Against the prior quarter it is down 213.8%.

Cash & Debt
$94.6M
YoY+41.8%
QoQ+29.8%
5Y CAGR+71.9%
10Y CAGR+23.1%

Harrow, Inc. 11.875% Senior Notes due 2027 held $94.6M in cash against $300.0M in long-term debt as of Q1 2026.

Shares Outstanding
37M
YoY+4.4%
QoQ0.0%
5Y CAGR+7.5%
10Y CAGR+11.0%

Harrow, Inc. 11.875% Senior Notes due 2027 had 37M shares outstanding in Q1 2026. This represents an increase of 4.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin
61.2%
YoY-6.4pp
QoQ-18.1pp
5Y change-14.4pp
10Y change+12.5pp

Harrow, Inc. 11.875% Senior Notes due 2027's gross margin was 61.2% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 6.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 18.1 percentage points.

Operating Margin
-50.0%
YoY-26.5pp
QoQ-67.5pp
5Y change-68.8pp
10Y change+35.7pp

Harrow, Inc. 11.875% Senior Notes due 2027's operating margin was -50.0% in Q1 2026, reflecting core business profitability. This is down 26.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 67.5 percentage points.

Net Margin
-62.4%
YoY-25.3pp
QoQ-69.9pp
5Y change-63.8pp

Harrow, Inc. 11.875% Senior Notes due 2027's net profit margin was -62.4% in Q1 2026, showing the share of revenue converted to profit. This is down 25.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 69.9 percentage points.

Return on Equity
-96.2%
YoY-64.7pp
QoQ-108.8pp
5Y change-96.9pp
10Y change-45.0pp

Harrow, Inc. 11.875% Senior Notes due 2027's ROE was -96.2% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 64.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 108.8 percentage points.

Capital Allocation

R&D Spending
$5.9M
YoY+94.8%
QoQ-49.7%
5Y CAGR+58.4%
10Y CAGR+62.5%

Harrow, Inc. 11.875% Senior Notes due 2027 invested $5.9M in research and development in Q1 2026. This represents an increase of 94.8% from the same quarter a year earlier. Against the prior quarter it is down 49.7%.

Capital Expenditures
$194K
YoY+14.1%
QoQ-43.1%
5Y CAGR-1.7%
10Y CAGR-22.1%

Harrow, Inc. 11.875% Senior Notes due 2027 invested $194K in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 14.1% from the same quarter a year earlier. Against the prior quarter it is down 43.1%.

Share Buybacks

Not reported for Q1 2026.

HROWM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HROWM quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$44.2M-7.6%$89.1M+33.3%$71.6M+45.4%$63.7M+30.2%$47.8M+38.3%$66.8M+83.8%$49.3M+43.8%$48.9M+46.2%
Cost of Revenue$17.2M+10.5%$18.5M+30.7%$17.7M+47.4%$16.2M+29.4%$15.5M+47.1%$14.1M+25.1%$12.0M+19.4%$12.5M+25.4%
Gross Profit$27.0M-16.3%$70.6M+34.0%$53.9M+44.8%$47.5M+30.5%$32.3M+34.4%$52.7M+110.3%$37.2M+53.9%$36.4M+55.1%
R&D Expenses$5.9M+94.8%$11.7M+146.5%$3.3M+46.2%$2.9M-6.1%$3.0M+40.8%$4.8M+42.5%$2.3M+60.0%$3.1M+163.0%
SG&A Expenses$43.2M+6.7%$43.3M+24.5%$35.9M+6.6%$33.2M+4.5%$40.5M+40.6%$34.8M+32.7%$33.6M+60.0%$31.8M+59.4%
Operating Income-$22.1M-96.6%$15.6M+20.9%$14.7M+1016.4%$11.4M+645.7%-$11.2M-62.1%$12.9M+364.6%$1.3M-24.3%$1.5M-34.9%
EBITDA-$21.6M-100.8%$16.4M+19.8%$15.1M+801.5%$11.8M+542.1%-$10.8M-65.7%$13.7M+242.6%$1.7M-63.8%$1.8M-66.2%
Interest Expense$5.5M-16.1%$5.2M-18.7%$6.0M+9.3%$6.4M+17.1%$6.5M+20.9%$6.4M+24.4%$5.5M-3.9%$5.5M-4.1%
Income Tax$25KN/AN/AN/AN/AN/A$20K-98.7%$655K+4466.7%
Net Income-$27.6M-55.2%$6.6M-2.2%$1.0M+124.2%$5.0M+177.2%-$17.8M-31.1%$6.8M+174.1%-$4.2M+3.9%-$6.5M-53.1%
EPS (Basic)-$0.74-48.0%N/A$0.03+125.0%$0.14+177.8%-$0.50-31.6%N/A-$0.12+7.7%-$0.18-28.6%
EPS (Diluted)-$0.74-48.0%N/A$0.03+125.0%$0.13+172.2%-$0.50-31.6%N/A-$0.12+7.7%-$0.18-28.6%
Diluted Shares (Avg)37M+3.9%N/A39M+8.9%39M+9.1%36M+1.0%N/A36M+4.2%36M+16.9%

HROWM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HROWM quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Total Assets$419.5M+15.2%$399.5M+2.7%$363.1M+3.3%$345.0M+12.5%$364.2M+23.2%$389.0M+24.6%$351.5M+22.9%$306.6M+36.9%
Current Assets$226.4M+33.5%$211.8M+11.7%$177.6M+20.8%$154.9M+11.1%$169.5M+35.1%$189.7M+36.0%$147.1M+33.4%$139.4M+131.2%
Cash & Equivalents$94.6M+41.8%$72.9M+54.4%$74.3M+2.3%$53.0M-25.4%$66.7M-2.6%$47.2M-36.2%$72.6M+10.7%$71.0M+211.9%
Inventory$16.5M+53.9%$13.5M+26.4%$12.8M+26.4%$11.6M+22.6%$10.7M-0.9%$10.7M-1.5%$10.2M+13.8%$9.4M+10.2%
Accounts Receivable$101.3M+31.4%$110.9M-4.7%$77.6M+44.4%$78.8M+51.6%$77.1M+166.1%$116.4M+220.9%$53.7M+191.0%$52.0M+184.7%
Goodwill$332K0.0%$332K0.0%$332K0.0%$332K0.0%$332K0.0%$332K0.0%$332K0.0%$332K0.0%
Total Liabilities$391.2M+27.0%$347.4M+8.7%$316.4M+7.7%$295.7M+19.0%$308.1M+30.9%$319.7M+32.2%$293.9M+39.5%$248.5M+23.0%
Current Liabilities$91.4M-51.1%$96.3M+5.4%$65.4M-31.2%$248.9M+364.8%$187.0M+347.8%$91.3M+85.1%$95.0M+399.3%$53.6M+132.7%
Non-Current Liabilities$299.8M+147.6%$251.1M+10.0%$251.0M+26.2%$46.9M-76.0%$121.1M-37.5%$228.3M+18.7%$198.9M+3.8%$194.9M+8.9%
Long-Term Debt$300.0M+16.8%$250.0M-4.8%N/A$250.6M+6.1%$256.9M+5.5%$262.7M+6.5%$230.7M$236.3M
Total Equity$28.7M-49.1%$52.4M-24.7%$47.0M-18.9%$49.7M-15.2%$56.5M-6.8%$69.7M-1.6%$58.0M-23.5%$58.5M+161.2%
Retained Earnings-$184.1M-8.8%-$156.5M-3.4%-$163.2M-3.2%-$164.2M-6.6%-$169.2M-14.7%-$151.4M-13.1%-$158.2M-26.8%-$153.9M-27.9%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.

HROWM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HROWM quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Operating Cash Flow-$9.0M-145.7%$8.4M+147.3%$16.6M+462.1%-$803K+70.8%$19.7M+525.0%-$17.8M-304.5%$3.0M+344.3%-$2.7M-160.1%
Depreciation & Amortization$455K-2.2%$777K+1.4%$326K-7.1%$347K+15.3%$465K+7.6%$766K+116.3%$351K-87.8%$301K-90.2%
Stock-Based Compensation$3.8M-15.8%N/A$3.3M-25.4%$875K-79.5%$4.6M+9.3%N/A$4.4M-2.0%$4.3M-21.1%
Capital Expenditures$194K+14.1%$341K-38.6%$210K-65.2%$166K-51.7%$170K+84.8%$555K+186.1%$604K+16.2%$344K+37.6%
Free Cash Flow-$9.2M-147.1%$8.1M+144.0%$16.4M+597.8%-$969K+68.6%$19.5M+513.1%-$18.3M-315.6%$2.3M+235.8%-$3.1M-171.6%
Investing Cash Flow-$18.2M-8486.3%-$4.7M+87.4%-$225K+62.3%-$293K-105.7%-$212K-92.7%-$37.6M-18402.5%-$597K+97.0%$5.1M+508.6%
Financing Cash Flow$48.9M+212560.9%-$5.0M-116.8%$5.0M+788.5%-$12.7M-17452.1%$23K+102.8%$30.0M+166683.3%-$721K-101.1%$73K-61.4%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

HROWM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HROWM quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Gross Margin61.2%-6.4pp79.3%+0.4pp75.3%-0.3pp74.5%+0.2pp67.5%-1.9pp78.8%+9.9pp75.6%+5.0pp74.4%+4.3pp
Operating Margin-50.0%-26.5pp17.5%-1.8pp20.6%+17.9pp17.9%+14.8pp-23.5%-3.5pp19.3%+32.7pp2.7%-2.4pp3.1%-3.9pp
Net Margin-62.4%-25.3pp7.4%-2.7pp1.4%+10.0pp7.8%+21.1pp-37.2%+2.1pp10.1%+35.3pp-8.6%+4.2pp-13.2%-0.6pp
Return on Equity-96.2%-64.7pp12.6%+2.9pp2.2%+9.4pp10.1%+21.1pp-31.5%-9.1pp9.7%+22.7pp-7.3%-1.5pp-11.1%+7.8pp
Return on Assets-6.6%-1.7pp1.7%-0.1pp0.3%+1.5pp1.5%+3.6pp-4.9%-0.3pp1.7%+4.7pp-1.2%+0.3pp-2.1%-0.2pp
Current Ratio2.48+1.6x2.20+0.1x2.72+1.2x0.62-2.0x0.91-2.1x2.08-0.8x1.55-4.2x2.600.0x
Debt-to-Equity10.45+5.9x4.77+1.0x6.73+2.8x5.05+1.0x4.55+0.5x3.77+0.3x3.98+1.2x4.04-5.0x
Asset Turnover0.110.0x0.22+0.1x0.20+0.1x0.180.0x0.130.0x0.17+0.1x0.140.0x0.160.0x
FCF Margin-20.8%-61.5pp9.1%+36.5pp22.9%+18.1pp-1.5%+4.8pp40.8%+54.4pp-27.4%-50.8pp4.8%+9.8pp-6.3%-19.2pp

Frequently Asked Questions

What is Harrow, Inc. 11.875% Senior Notes due 2027's annual revenue?

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) reported $272.3M in total revenue for fiscal year 2025. This represents a 36.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Harrow, Inc. 11.875% Senior Notes due 2027's revenue growing?

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) revenue grew by 36.4% year-over-year, from $199.6M to $272.3M in fiscal year 2025.

Is Harrow, Inc. 11.875% Senior Notes due 2027 profitable?

No, Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) reported a net income of -$5.1M in fiscal year 2025, with a net profit margin of -1.9%.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) reported diluted earnings per share of -$0.14 for fiscal year 2025. This represents a 71.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had EBITDA of $32.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had $72.9M in cash and equivalents against $250.0M in long-term debt.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had a gross margin of 75.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had an operating margin of 11.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had a net profit margin of -1.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) has a return on equity of -9.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) generated $43.0M in free cash flow during fiscal year 2025. This represents a 280.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) generated $43.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had $399.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) invested $887K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) invested $20.9M in research and development during fiscal year 2025.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had 37M shares outstanding as of fiscal year 2025.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had a current ratio of 2.20 as of fiscal year 2025, which is generally considered healthy.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had a debt-to-equity ratio of 4.77 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) had a return on assets of -1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) reported a net loss of $5.1M while generating $43.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) has an interest coverage ratio of 1.26x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top